Skip to main content

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Silvia Cabrera Diaz

Institutions of which they are part

Main researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Cytomark - Desarrollo de un test diagnóstico personalizado y no invasivo de cáncer de endometrio en el fluido cervical

IP: Eva Colas Ortega
Collaborators: Angel García Jiménez, Silvia Cabrera Diaz, Antonio Gil Moreno, Melek Denizli
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: AC21_2/00030
Duration: 01/01/2022 - 31/12/2024

ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER

IP: Eva Colas Ortega
Collaborators: Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/00644
Duration: 01/01/2021 - 31/12/2024

-

IP: Silvia Cabrera Diaz
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: PI17/02155_INT_CABRERA
Duration: 01/02/2019 - 30/06/2022

Desarrollo de una herramienta de diagnóstico precoz de cáncer de endometrio en biopsia líquida cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Maria Cristina Centeno Mediavilla, Silvia Franco Camps, Silvia Cabrera Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI17/02155
Duration: 01/01/2018 - 30/06/2022

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Natalia Borruel Sainz

Natalia Borruel Sainz

Physiology and Pathophysiology of the Digestive Tract
Read more
Tudela Marti, Roger

Tudela Marti, Roger

Administrative Assistant
Patronage Unit
Communication Area
Read more
Herrera Rey, Lara

Herrera Rey, Lara

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more
Maria Angeles Jiménez Fuentes

Maria Angeles Jiménez Fuentes

Pneumology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.